Ciresi, A., Vigneri, E., Radellini, S., Pantò, F., & Giordano, C. (2018). Author Correction: Liraglutide Improves Cardiovascular Risk as an Add-on to Metformin and Not to Insulin Secretagogues in Type 2 Diabetic Patients: A Real-life 48-Month Retrospective Study. Diabetes Ther.

Ciresi, Alessandro, Enrica Vigneri, Stefano Radellini, Felicia Pantò, and Carla Giordano. "Author Correction: Liraglutide Improves Cardiovascular Risk As an Add-on to Metformin and Not to Insulin Secretagogues in Type 2 Diabetic Patients: A Real-life 48-Month Retrospective Study." Diabetes Ther 2018.

Ciresi, Alessandro, et al. "Author Correction: Liraglutide Improves Cardiovascular Risk As an Add-on to Metformin and Not to Insulin Secretagogues in Type 2 Diabetic Patients: A Real-life 48-Month Retrospective Study." Diabetes Ther 2018.